1. Home
  2. CVM vs RGS Comparison

CVM vs RGS Comparison

Compare CVM & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • RGS
  • Stock Information
  • Founded
  • CVM 1983
  • RGS 1922
  • Country
  • CVM United States
  • RGS United States
  • Employees
  • CVM 44
  • RGS N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • RGS Other Consumer Services
  • Sector
  • CVM Health Care
  • RGS Consumer Discretionary
  • Exchange
  • CVM Nasdaq
  • RGS Nasdaq
  • Market Cap
  • CVM 60.9M
  • RGS 70.8M
  • IPO Year
  • CVM 1987
  • RGS 1991
  • Fundamental
  • Price
  • CVM $9.12
  • RGS $30.24
  • Analyst Decision
  • CVM
  • RGS
  • Analyst Count
  • CVM 0
  • RGS 0
  • Target Price
  • CVM N/A
  • RGS N/A
  • AVG Volume (30 Days)
  • CVM 82.9K
  • RGS 13.0K
  • Earning Date
  • CVM 08-14-2025
  • RGS 11-05-2025
  • Dividend Yield
  • CVM N/A
  • RGS N/A
  • EPS Growth
  • CVM N/A
  • RGS 20.23
  • EPS
  • CVM N/A
  • RGS 46.10
  • Revenue
  • CVM N/A
  • RGS $210,134,000.00
  • Revenue This Year
  • CVM N/A
  • RGS N/A
  • Revenue Next Year
  • CVM N/A
  • RGS N/A
  • P/E Ratio
  • CVM N/A
  • RGS $0.69
  • Revenue Growth
  • CVM N/A
  • RGS 3.52
  • 52 Week Low
  • CVM $1.98
  • RGS $15.00
  • 52 Week High
  • CVM $32.70
  • RGS $31.50
  • Technical
  • Relative Strength Index (RSI)
  • CVM 46.34
  • RGS 64.25
  • Support Level
  • CVM $8.61
  • RGS $29.33
  • Resistance Level
  • CVM $10.24
  • RGS $31.50
  • Average True Range (ATR)
  • CVM 0.68
  • RGS 0.97
  • MACD
  • CVM -0.13
  • RGS -0.17
  • Stochastic Oscillator
  • CVM 20.50
  • RGS 65.01

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: